Eton Pharmaceuticals (ETON) Current Leases (2019)
Eton Pharmaceuticals' (ETON) quarterly Current Leases came in at $133000.0 in Q4 2019.
Powered by 
Analysis
Eton Pharmaceuticals (ETON) Current Leases (2019) Analysis & Trends
Eton Pharmaceuticals has disclosed Current Leases across 1 years of filings, most recently posting $133000.0 for Q4 2019.
- In Q4 2019, Current Leases changed N/A year-over-year to $133000.0; the TTM figure through Dec 2019 stood at $133000.0 (changed N/A YoY), while the FY2019 annual figure was $133000.0, changed N/A from the prior year.
- Current Leases came in at $133000.0 for Q4 2019 at Eton Pharmaceuticals.
- In the past five years, Current Leases ranged from a high of $133000.0 in Q4 2019 to a low of $133000.0 in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 274.00 Mn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 263.86 Mn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 16.75 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 4.26 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Eton Pharmaceuticals | 1.63 Bn | 1.60 Bn | 25.41 Mn | - |